Evaluation of phototherapy on premature neonates

Not Applicable

• Conditions: Hyperbilirubinemia.; Other disorders of bilirubin metabolism; E80.6

• Registration Number: IRCT20211015052778N1
• Lead Sponsor: Boushehr University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Premature infants weighing 1500-2000 gr

Exclusion Criteria

Dissatisfaction with participating in the study
Asphyxia
Cerebral hemorrhage
Meningitis
Neurological problems such as seizures without jaundice
Structural brain problems
Hypoxia
Sepsis (positive blood culture)
ABO incompatibility
First-day jaundice

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total bilirubin. Timepoint: Measurement of total blood bilirubin at the beginning of the study (before the intervention) and then on days 1, 3, 5, 7 and 10 after birth. Method of measurement: In Shohadaye Khalije Fars Hospital, the bilirubin samples will be tested based on photometric principles and using Jendrssik Grof Assay kit from Biorex Fars Company through DIRUI CS-400 Auto-Chemistry Analyzer. In Salman Farsi Hospital, the bilirubin samples will be measured based on the same principles and kit used in the Shohadaye Khalije Fars Hospital using the DIRUI CS-400 Auto-Chemistry Analyzer.;Development. Timepoint: 2 and 4 month. Method of measurement: By ASQ questionnaire.